Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)

Clinical trial NCT00073450 · TERMINATED

Trial details

NCT number: NCT00073450
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell Head and Neck Neoplasms

Start date: 2003-09-01
Primary completion: 2004-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.